Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

UCLA’s HIV prevention and treatment centre receives $7.5 million NIH grant

March 21, 2022 Sales and Marketing

The National Institute of Mental Health has renewed its support for UCLA’s collaborative Centre for HIV Identification, Prevention and Treatment …
News

Merck’s Keytruda delivers reduced risk of death in adjuvant NSCLC

March 21, 2022 Sales and Marketing

Merck has announced positive results from its Phase III trial into Keytruda for non-small cell lung cancer. The KEYNOTE-091 study …
News

CanSinoBIO’s Convidecia effective as booster against Omicron

March 14, 2022 Sales and Marketing

According to an academic paper on the efficacy of CanSinoBIO’s recombinant COVID-19 vaccine, published on medRxiv, the vaccine is effective …
News
e-6olmfwuay74lr

UK Health Secretary: rise in COVID-19 cases ‘expected’

March 14, 2022 Sales and Marketing

A surge in COVID-19 cases was to be “expected”, following the ease of pandemic restrictions in England, insisted UK Health …
News

First and only approved medicine in US targeting BRCA mutations in early breast cancer

March 14, 2022 Sales and Marketing

LYNPARZA® (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative high-risk …
News

Malaysia to receive Pfizer’s COVID-19 pills in two weeks, says Health Minister

March 7, 2022 Sales and Marketing

Khairy Jamaluddin, Health Minister of Malaysia, has shared that the country expects to receive its first shipment of Pfizer’s oral …
News

HUTCHMED receives $15 million to begin Phase III study of lung cancer treatment

March 7, 2022 Sales and Marketing

HUTCHMED has received $15 million from AstraZeneca, for the initiation of start-up activities for SAFFRON, the first global Phase III …
News

AbbVie acquires Syndesi Therapeutics

March 7, 2022 Sales and Marketing

Syndesi Therapeutics has been acquired by AbbVie in a deal worth a potential $1 billion.Syndesi was created in 2018 as …
News

India: approval for drug treating CKD-associated anaemia

March 7, 2022 Sales and Marketing

Zydus Lifesciences received approval from the Drugs Controller General of India (DCGI) for its new drug application for Oxemia (Desidustat). …
News

Potential breakthrough trial for rare disease Hunter syndrome

February 28, 2022 Sales and Marketing

Actigen has initiated a clinical development programme for GNR-055, a potentially breakthrough treatment for the debilitating, life-limiting, rare disease mucopolysaccharidosis …
News

Phase III data show Dupixent reduced itch in chronic spontaneous urticaria patients

February 28, 2022 Sales and Marketing

Results from a Phase III trial have revealed that adding Dupixent (dupilumab) to standard-of-care antihistamines significanty reduced itch and hives …
News

Urgent need to address mental health crisis among kidney patients

February 28, 2022 Sales and Marketing

Kidney Research UK has released their findings from a survey of 1,000 kidney disease patients in the UK, revealing the …
News

Kapruvia receives positive CHMP opinion for pruritus in hemodialysis patients

February 28, 2022 Sales and Marketing

The CHMP has approved Kapruvia (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in hemodialysis patients. …
News

CanSinoBIO’s Convidecia approved as heterologous COVID-19 booster in China

February 21, 2022 Sales and Marketing

CanSino Biologics announced that its recombinant novel coronavirus vaccine has been approved by the Joint Prevention and Control Mechanism of …
News

FDA approval of first disease-modifying drug for treatment of rare lifelong anaemia

February 21, 2022 Sales and Marketing

Agios Pharmaceuticals has announced the FDA approval of Pyrukynd (mitapivat), for the treatment of haemolytic anaemia in adults with pyruvate …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026